Cargando…

Molecular insights into mineralotropic hormone inter-regulation

The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)). Early research efforts focused on PTH and 1,25(OH)(2)D(3) and more recently on FGF23 have revealed that each of these hormones regulates the expression of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pike, J. Wesley, Lee, Seong Min, Meyer, Mark B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334211/
https://www.ncbi.nlm.nih.gov/pubmed/37441497
http://dx.doi.org/10.3389/fendo.2023.1213361
_version_ 1785070814689755136
author Pike, J. Wesley
Lee, Seong Min
Meyer, Mark B.
author_facet Pike, J. Wesley
Lee, Seong Min
Meyer, Mark B.
author_sort Pike, J. Wesley
collection PubMed
description The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)). Early research efforts focused on PTH and 1,25(OH)(2)D(3) and more recently on FGF23 have revealed that each of these hormones regulates the expression of the other two. Despite early suggestions of transcriptional processes, it has been only recently that research effort have begun to delineate the genomic mechanisms underpinning this regulation for 1,25(OH)(2)D(3) and FGF23; the regulation of PTH by 1,25(OH)(2)D(3), however, remains obscure. We review here our molecular understanding of how PTH induces Cyp27b1 expression, the gene encoding the enzyme responsible for the synthesis of 1,25(OH)(2)D(3). FGF23 and 1,25(OH)(2)D(3), on the other hand, function by suppressing production of 1,25(OH)(2)D(3). PTH stimulates the PKA-induced recruitment of CREB and its coactivator CBP at CREB occupied sites within the kidney-specific regulatory regions of Cyp27b1. PKA activation also promotes the nuclear translocation of SIK bound coactivators such as CRTC2, where it similarly interacts with CREB occupied Cyp27b1 sites. The negative actions of both FGF23 and 1,25(OH)(2)D(3) appear to suppress Cyp27b1 expression by opposing the recruitment of CREB coactivators at this gene. Reciprocal gene actions are seen at Cyp24a1, the gene encoding the enzyme that degrades 1,25(OH)(2)D(3), thereby contributing to the overall regulation of blood levels of 1,25(OH)(2)D(3). Relative to PTH regulation, we summarize what is known of how 1,25(OH)(2)D(3) regulates PTH suppression. These studies suggest that it is not 1,25(OH)(2)D(3) that controls PTH levels in healthy subjects, but rather calcium itself. Finally, we describe current progress using an in vivo approach that furthers our understanding of the regulation of Fgf23 expression by PTH and 1,25(OH)(2)D(3) and provide the first evidence that P may act to induce Fgf23 expression via a complex transcriptional mechanism in bone. It is clear, however, that additional advances will need to be made to further our understanding of the inter-regulation of each of these hormonal genes.
format Online
Article
Text
id pubmed-10334211
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103342112023-07-12 Molecular insights into mineralotropic hormone inter-regulation Pike, J. Wesley Lee, Seong Min Meyer, Mark B. Front Endocrinol (Lausanne) Endocrinology The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)). Early research efforts focused on PTH and 1,25(OH)(2)D(3) and more recently on FGF23 have revealed that each of these hormones regulates the expression of the other two. Despite early suggestions of transcriptional processes, it has been only recently that research effort have begun to delineate the genomic mechanisms underpinning this regulation for 1,25(OH)(2)D(3) and FGF23; the regulation of PTH by 1,25(OH)(2)D(3), however, remains obscure. We review here our molecular understanding of how PTH induces Cyp27b1 expression, the gene encoding the enzyme responsible for the synthesis of 1,25(OH)(2)D(3). FGF23 and 1,25(OH)(2)D(3), on the other hand, function by suppressing production of 1,25(OH)(2)D(3). PTH stimulates the PKA-induced recruitment of CREB and its coactivator CBP at CREB occupied sites within the kidney-specific regulatory regions of Cyp27b1. PKA activation also promotes the nuclear translocation of SIK bound coactivators such as CRTC2, where it similarly interacts with CREB occupied Cyp27b1 sites. The negative actions of both FGF23 and 1,25(OH)(2)D(3) appear to suppress Cyp27b1 expression by opposing the recruitment of CREB coactivators at this gene. Reciprocal gene actions are seen at Cyp24a1, the gene encoding the enzyme that degrades 1,25(OH)(2)D(3), thereby contributing to the overall regulation of blood levels of 1,25(OH)(2)D(3). Relative to PTH regulation, we summarize what is known of how 1,25(OH)(2)D(3) regulates PTH suppression. These studies suggest that it is not 1,25(OH)(2)D(3) that controls PTH levels in healthy subjects, but rather calcium itself. Finally, we describe current progress using an in vivo approach that furthers our understanding of the regulation of Fgf23 expression by PTH and 1,25(OH)(2)D(3) and provide the first evidence that P may act to induce Fgf23 expression via a complex transcriptional mechanism in bone. It is clear, however, that additional advances will need to be made to further our understanding of the inter-regulation of each of these hormonal genes. Frontiers Media S.A. 2023-06-27 /pmc/articles/PMC10334211/ /pubmed/37441497 http://dx.doi.org/10.3389/fendo.2023.1213361 Text en Copyright © 2023 Pike, Lee and Meyer https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Pike, J. Wesley
Lee, Seong Min
Meyer, Mark B.
Molecular insights into mineralotropic hormone inter-regulation
title Molecular insights into mineralotropic hormone inter-regulation
title_full Molecular insights into mineralotropic hormone inter-regulation
title_fullStr Molecular insights into mineralotropic hormone inter-regulation
title_full_unstemmed Molecular insights into mineralotropic hormone inter-regulation
title_short Molecular insights into mineralotropic hormone inter-regulation
title_sort molecular insights into mineralotropic hormone inter-regulation
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334211/
https://www.ncbi.nlm.nih.gov/pubmed/37441497
http://dx.doi.org/10.3389/fendo.2023.1213361
work_keys_str_mv AT pikejwesley molecularinsightsintomineralotropichormoneinterregulation
AT leeseongmin molecularinsightsintomineralotropichormoneinterregulation
AT meyermarkb molecularinsightsintomineralotropichormoneinterregulation